James Willard

Center for Drug Evaluation and Research — United States

Medicine · Health Sciences

12h-index550citations26works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiac electrophysiology and arrhythmias(6), Blood Pressure and Hypertension Studies(3), Wound Healing and Treatments(3), Retinal Diseases and Treatments(2), Meta-analysis and systematic reviews(2)

Publications26 total

The Challenges of Predicting Drug-Induced QTc Prolongation in Humans
Toxicological Sciences·2022· 42 citedOpen Access
Robust demographically-adjusted normative data for the Montreal Cognitive Assessment (MoCA): Results from the systolic blood pressure intervention trial
The Clinical Neuropsychologist·2021· 26 citedOpen Access
Detection of Cognitive Impairment after Critical Illness with the Medicare Annual Wellness Visit: A Cohort Study
Annals of the American Thoracic Society·2021· 4 citedOpen Access
Effect of Intensive Versus Standard Blood Pressure Control on Stroke Subtypes
Hypertension·2021· 5 citedOpen Access
Automated Frailty Screening At‐Scale for Pre‐Operative Risk Stratification Using the Electronic Frailty Index
Journal of the American Geriatrics Society·2021· 61 citedOpen Access
Effectiveness of a Nurse-Led Multidisciplinary Intervention vs Usual Care on Advance Care Planning for Vulnerable Older Adults in an Accountable Care Organization
JAMA Internal Medicine·2021· 73 citedOpen Access
Promoting Active Aging: Lessons Learned in an Implementation Pilot in Primary Care
Journal of the American Geriatrics Society·2020· 11 citedOpen Access
Screening for Post-ICU Cognitive Impairment in Older Adults Using the Medicare Annual Wellness Visit: A Cohort Study
2020
Prediction of drug-effects on cardiac repolarization in humans: What can we learn from the past to refine our drug discovery strategies?
Journal of Pharmacological and Toxicological Methods·2019
Characterizing Adversity of Lysosomal Accumulation in Nonclinical Toxicity Studies: Results from the 5th ESTP International Expert Workshop
Toxicologic Pathology·2018· 31 citedOpen Access
Can non‐clinical repolarization assays predict the results of clinical thorough QT studies? Results from a research consortium
British Journal of Pharmacology·2017· 65 citedOpen Access
Can Nonclinical Repolarization Assays Predict the Results of Clinical Thorough QT Studies? A HESI-FDA Retrospective Analysis
Journal of Pharmacological and Toxicological Methods·2017
Burn Scar Biomechanics after Pressure Garment Therapy
Plastic & Reconstructive Surgery·2015· 49 citedOpen Access
The impact of drug-related QT prolongation on FDA regulatory decisions
International Journal of Cardiology·2013· 35 cited
Plant-Derived Human Collagen Scaffolds for Skin Tissue Engineering
Tissue Engineering Part A·2013· 84 citedOpen Access
The effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healing
Clinical ophthalmology·2013· 19 citedOpen Access
The effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healing
SHILAP Revista de lepidopterología·2013Open Access
Assessment of the concordance between nonclinical repolarization assays and clinical measure of QT interval prolongation
Journal of Pharmacological and Toxicological Methods·2012
Mechano-modulation of burn wound repair
The Knowledge Bank (The Ohio State University)·2012Open Access
Abstract 5180: RNAi-mediated diminution of myoferlin increases adhesion of breast cancer cells
Cancer Research·2012
page 1 of 2Next →

Frequent Co-authors

Heather M. Powell(6), Jeff D. Williamson(6), John Koerner(6), Nicholas M. Pajewski(5), Kathryn E. Callahan(5), Matthew Skinner(5), Gary A. Gintant(4), Jennifer Pierson(4), Todd Wisialowski(4), Jean‐Pierre Valentin(4), Albert DeFelice(4), John Lawrence(4), James Hung(4), Shari Targum(4), Douglas C. Throckmorton(4), John Girton(4), Stephen P. Glasser(4), Raymond J. Lipicky(4), Daoqin Bi(3), Devi Kozeli(3)